Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Pediatric Transplantation|June 3, 2016
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decadesPetter Svenberg, Mats Remberger, Mehmet Uzunel, et al.Pediatric Blood & Cancer|May 23, 2014
Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescenceMari Wilhelmsson, Anu Vatanen, Birgit Borgström, et al.Plos One|August 24, 2012
Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseasesStephan Borte, Magdalena Janzi, Qiang Pan-Hammarström, et al.Clinical Immunology (Orlando, Fla.)|January 18, 2017
NEIL1 is a candidate gene associated with common variable immunodeficiency in a patient with a chromosome 15q24 deletionRosa Romano, Apostolos Zaravinos, Kyriaki Liadaki, et al.Stem Cells Translational Medicine|March 14, 2018
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host DiseaseOlle Ringden, Arjang Baygan, Mats Remberger, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2020
Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trialTove Kamsvåg, Anncarin Svanberg, Karin Garming Legert, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantationMagnus E A Hansson, Anna-Carin Norlin, Brigitta Omazic, et al.Journal of Clinical Immunology|November 23, 2016
Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening StudyMichela Barbaro, Annika Ohlsson, Stephan Borte, et al.Haematologica|September 24, 2016
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationJohan Törlén, Olle Ringdén, Karin Garming-Legert, et al.Haematologica|September 24, 2013
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationMichael Uhlin, Helena Wikell, Mikael Sundin, et al.Pageof 8